- Home
- CVGI vs QNTM Comparison
CVGI vs QNTM Comparison
Compare CVGI & QNTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVGI
- QNTM
- Stock Information
- Founded
- CVGI 2000
- QNTM 1998
- Country
- CVGI United States
- QNTM Canada
- Employees
- CVGI N/A
- QNTM N/A
- Industry
- CVGI Auto Parts:O.E.M.
- QNTM
- Sector
- CVGI Consumer Discretionary
- QNTM
- Exchange
- CVGI Nasdaq
- QNTM NYSE
- Market Cap
- CVGI 34.0M
- QNTM 35.6M
- IPO Year
- CVGI 2004
- QNTM N/A
- Fundamental
- Price
- CVGI $1.45
- QNTM $15.46
- Analyst Decision
- CVGI Buy
- QNTM
- Analyst Count
- CVGI 1
- QNTM 0
- Target Price
- CVGI $10.00
- QNTM N/A
- AVG Volume (30 Days)
- CVGI 447.6K
- QNTM 231.8K
- Earning Date
- CVGI 05-06-2025
- QNTM 05-14-2025
- Dividend Yield
- CVGI N/A
- QNTM N/A
- EPS Growth
- CVGI N/A
- QNTM N/A
- EPS
- CVGI N/A
- QNTM N/A
- Revenue
- CVGI $698,524,000.00
- QNTM N/A
- Revenue This Year
- CVGI N/A
- QNTM N/A
- Revenue Next Year
- CVGI $6.12
- QNTM N/A
- P/E Ratio
- CVGI N/A
- QNTM N/A
- Revenue Growth
- CVGI N/A
- QNTM N/A
- 52 Week Low
- CVGI $0.81
- QNTM $2.70
- 52 Week High
- CVGI $5.69
- QNTM $23.81
- Technical
- Relative Strength Index (RSI)
- CVGI 58.18
- QNTM 78.71
- Support Level
- CVGI $1.28
- QNTM $10.75
- Resistance Level
- CVGI $1.41
- QNTM $15.65
- Average True Range (ATR)
- CVGI 0.10
- QNTM 1.56
- MACD
- CVGI 0.00
- QNTM 0.39
- Stochastic Oscillator
- CVGI 70.37
- QNTM 97.46
About CVGI Commercial Vehicle Group Inc.
Commercial Vehicle Group Inc is a provider of systems, assemblies, and components to the commercial vehicle market and the electric vehicle markets. It delivers solutions to complex design, engineering, and manufacturing problems while creating positive change for customers, industries, and communities. Its operating segments are Vehicle Solutions, Electrical Systems, and Aftermarket and Accessories. The company makes the majority of its revenue from Vehicle Solutions. The group generates revenue from its products including seating systems, plastic components, electrical wire harnesses, mirrors, wipers, and other accessories. Its geographic regions are North America, Europe and Asia-Pacific.
About QNTM QUANTUM BIOPHARMA LTD
Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.